Key Points
- Broadwood Partners continued a large accumulation of STAAR stock with purchases including 336,946 shares on Jan. 6 (~$21.62/share) and 66,467 shares on Jan. 7 ($22.00/share), bringing its direct holding to 15,422,904 shares valued at about $339.3 million (a 0.43% increase).
- The proposed $1.6 billion takeover by Alcon was terminated after shareholders rejected the deal, leaving STAAR independent and creating near‑term strategic uncertainty for the company.
- Wall Street sentiment is lukewarm — ten Hold ratings and one Sell produce an average price target of $23.42 while STAAR trades with a market cap around $1.12 billion and a one‑year range of $13.50–$30.81.
STAAR Surgical Company (NASDAQ:STAA - Get Free Report) major shareholder Broadwood Partners, L.P. acquired 3,240 shares of the company's stock in a transaction dated Thursday, January 8th. The shares were purchased at an average cost of $21.94 per share, for a total transaction of $71,085.60. Following the purchase, the insider directly owned 15,426,144 shares in the company, valued at approximately $338,449,599.36. This trade represents a 0.02% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Major shareholders that own at least 10% of a company's shares are required to disclose their sales and purchases with the SEC.
Broadwood Partners, L.P. also recently made the following trade(s):
- On Wednesday, January 7th, Broadwood Partners, L.P. bought 66,467 shares of STAAR Surgical stock. The stock was purchased at an average price of $22.00 per share, with a total value of $1,462,274.00.
- On Tuesday, January 6th, Broadwood Partners, L.P. purchased 336,946 shares of STAAR Surgical stock. The shares were purchased at an average price of $21.62 per share, for a total transaction of $7,284,772.52.
- On Wednesday, November 19th, Broadwood Partners, L.P. acquired 309,132 shares of STAAR Surgical stock. The stock was purchased at an average cost of $26.42 per share, with a total value of $8,167,267.44.
- On Friday, November 21st, Broadwood Partners, L.P. bought 797,486 shares of STAAR Surgical stock. The shares were purchased at an average cost of $27.86 per share, for a total transaction of $22,217,959.96.
- On Thursday, November 20th, Broadwood Partners, L.P. purchased 393,382 shares of STAAR Surgical stock. The stock was acquired at an average price of $27.14 per share, with a total value of $10,676,387.48.
STAAR Surgical Trading Up 1.4%
NASDAQ STAA opened at $22.50 on Friday. The stock has a market capitalization of $1.12 billion, a price-to-earnings ratio of -11.54 and a beta of 1.00. The stock has a 50-day moving average of $25.09 and a 200 day moving average of $24.37. STAAR Surgical Company has a twelve month low of $13.50 and a twelve month high of $30.81.
Hedge Funds Weigh In On STAAR Surgical
Several institutional investors and hedge funds have recently bought and sold shares of STAA. Amalgamated Bank grew its stake in shares of STAAR Surgical by 3.6% in the 3rd quarter. Amalgamated Bank now owns 14,609 shares of the medical instruments supplier's stock valued at $393,000 after buying an additional 514 shares during the period. CWM LLC lifted its holdings in STAAR Surgical by 74.1% in the second quarter. CWM LLC now owns 1,563 shares of the medical instruments supplier's stock valued at $26,000 after acquiring an additional 665 shares during the last quarter. GAMMA Investing LLC grew its position in STAAR Surgical by 61.4% in the third quarter. GAMMA Investing LLC now owns 1,856 shares of the medical instruments supplier's stock worth $50,000 after acquiring an additional 706 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its stake in STAAR Surgical by 7.8% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 12,711 shares of the medical instruments supplier's stock worth $213,000 after acquiring an additional 923 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC raised its position in STAAR Surgical by 4.4% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 22,168 shares of the medical instruments supplier's stock valued at $396,000 after purchasing an additional 934 shares during the period. 96.70% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
STAA has been the subject of a number of research analyst reports. BTIG Research restated a "neutral" rating on shares of STAAR Surgical in a research report on Tuesday. Piper Sandler restated a "neutral" rating on shares of STAAR Surgical in a research report on Monday, October 27th. Weiss Ratings reaffirmed a "sell (d)" rating on shares of STAAR Surgical in a research note on Wednesday, October 8th. Wells Fargo & Company boosted their price objective on STAAR Surgical from $28.00 to $30.75 and gave the stock an "equal weight" rating in a research note on Wednesday, December 10th. Finally, Needham & Company LLC restated a "hold" rating on shares of STAAR Surgical in a research report on Tuesday. Ten research analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Reduce" and an average target price of $23.42.
Check Out Our Latest Stock Report on STAAR Surgical
About STAAR Surgical
(
Get Free Report)
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
